data13F

NAMS – Newamsterdam Pharma Co NV

Held by 1 of 30 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares3,357,146
Combined reported value$81.6M

NAMS chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Stanley Druckenmiller narrow view 1.97 Added 9.3%3,357,146$81.6MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Added 9.3%3,357,1460.17
Q4 2025Stanley Druckenmiller narrow view Added 59.6%3,070,1460.95

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Added 9.3%3,357,1460.17
Q4 2025Stanley Druckenmiller narrow view Added 59.6%3,070,1460.95

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

1 peakQ3 2026: 1 tracked investors
Q3 2024: 1 tracked investorsQ4 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20242026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Stanley Druckenmiller3.36M3.07M3.07M3.07M1.92M832.2K800.4K287.5K

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).